Teva- Pharmaceutical Industries Ltd. ADR’s filing revealed that its Director MIGNONE ROBERTO unloaded Company’s shares for reported $6.29 million on Dec 20 ’24. In the deal valued at $22.01 per share,286,000 shares were sold. As a result of this transaction, MIGNONE ROBERTO now holds 695,000 shares worth roughly $14.21 million.
Then, Bridger Management, LLC (1) bought 286,000 shares, generating $6,094,660 in total proceeds.
Before that, Fox Christine sold 19,388 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $327,085 were divested by the EVP, Head of U.S. Commercial at a price of $16.87 per share. As a result of the transaction, Fox Christine now holds 44,104 shares, worth roughly $0.9 million.
Argus upgraded its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early March from “an Underweight” to “a Neutral”. Piper Sandler also remained covering TEVA and has increased its forecast on February 12, 2024 with a “an Overweight” recommendation from previously “Neutral” rating. Jefferies revised its rating on January 23, 2024. It rated TEVA as “a Buy” which previously was an “a Hold”.
Price Performance Review of TEVA
On Monday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock fall -2.39% to $20.44. Over the last five days, the stock has lost -3.77%. Teva- Pharmaceutical Industries Ltd. ADR shares have fallen nearly -7.26% since the year began. Nevertheless, the stocks have risen 77.89% over the past one year. While a 52-week high of $22.80 was reached on 01/02/25, a 52-week low of $10.83 was recorded on 01/13/25. SMA at 50 days reached $18.76, while 200 days put it at $17.16.
Levels Of Support And Resistance For TEVA Stock
The 24-hour chart illustrates a support level at 20.07, which if violated will result in even more drops to 19.69. On the upside, there is a resistance level at 20.89. A further resistance level may holdings at 21.34. The Relative Strength Index (RSI) on the 14-day chart is 51.29, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.80, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.89%. Stochastics %K at 21.10% indicates the stock is a holding.
How much short interest is there in Teva- Pharmaceutical Industries Ltd. ADR?
A steep rise in short interest was recorded in Teva- Pharmaceutical Industries Ltd. ADR stocks on 2024-12-31, growing by 4.72 million shares to a total of 27.13 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 22.41 million shares. There was a rise of 17.41%, which implies that there is a positive sentiment for the stock.
